| Followed By | 66 |
| Posts | 1303 |
| Boards Moderated | 1 |
| Alias Born | 01/29/2015 |
ILUS Confirms Its Second Quarter of 2022 Results, Including a 553% Revenue Increase Over Its Previous Quarter, to $19,677,222 • ILUS • Aug 15, 2022 2:52 PM
S.E.C.-registered HYUNDAI brand consumer technologies enters the U.S. market with a $100 million stocks and bond offering Aug 15, 2022 12:04 PM
Branded Legacy, Inc. Reduces Issued and Outstanding Shares By 46% • BLEG • Aug 15, 2022 8:30 AM
Green Battery Minerals Receives Assays from Drilling into Graphite Outcrops on Zone 1. Intersecting 19.5 metres of 35.52% Grade Graphite and 51.20 meters of 22.61% Grade Graphite. • GEM • Aug 12, 2022 6:07 PM
Alliance Creative Group (ACGX) Reports Revenue of $2,974,489 for Second Quarter of 2022 • ACGX • Aug 12, 2022 12:40 PM
Progressive Care Reports Second Quarter 2022 Results Highlighted by 4% Growth to $10.0 Million in Revenue • RXMD • Aug 12, 2022 10:21 AM
PJET Bullish Investment Message Garners New Investment Interest • PJET • Aug 12, 2022 9:53 AM
VAYK Real Estate Fintech Strategy Builds Momentum and Explores Stock Buyback • VAYK • Aug 12, 2022 9:46 AM
Branded Legacy, Inc. Eliminates Over 430 Thousand In Debt In 2022 • BLEG • Aug 12, 2022 9:15 AM
InnerScope Hearing Technologies (OTC: INND) Reports Record Revenues for a Profitable Q2 2022 • INND • Aug 12, 2022 8:00 AM
Pro Music Rights, Inc., one of the world's largest music licensing companies, announces that it intends to Release its Financials by August 19, 2022 • NUVG • Aug 11, 2022 11:11 AM
AXTG Partner with Save Planet Earth to digitize and plant 100 million trees with NFTs • AXTG • Aug 11, 2022 10:15 AM
PURA Announces New Development Expanding Cannabis Market Opportunity • PURA • Aug 11, 2022 9:34 AM
Pasithea Therapeutics Announces Results of Preclinical Study Demonstrating Tolerizing Vaccine Efficacy in Relapsing-Remitting Model of Multiple Sclerosis • KTTA • Aug 11, 2022 8:35 AM
SinglePoint Acquires Frontline Power Solutions, a Multi-State Licensed Energy Services Company • SING • Aug 11, 2022 8:30 AM
Follow Board